Metformin modulates metabolism in multiple cell types and is currently used to reduce glucose levels and insulin resistance in diabetic patients. The investigators hypothesize that oral metformin can regulate the metabolism of CD8+ T cells, reduce their cytotoxic activity and thus serve as a novel treatment for vitiligo.
1 Primary · 3 Secondary · Reporting Duration: Week 24
30 Total Participants · 1 Treatment Group
Primary Treatment: Oral Metformin · No Placebo Group · Phase 2
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
|18 - 65||100.0%|
|UMass Chan Medical School||100.0%|
|Did not meet criteria||50.0%|